Latest papers

In vivo CXCR4 expression, lymphoid cell phenotype, and feline immunodeficiency virus infection.

[FIV: not a death sentence].

Expression of CD134 and CXCR4 mRNA in term placentas from FIV-infected and control cats.

Advances in FIV vaccine technology.

Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection.

Lentivirus-induced immune dysregulation.

Should accessory proteins be structural components of lentiviral vaccines? Lessons learned from the accessory ORF-A protein of FIV.

A new fluorimetric assay to measure cytotoxic T-lymphocyte activity against feline immunodeficiency virus envelope glycoprotein.

Evolution of feline immunodeficiency virus in Felidae: implications for human health and wildlife ecology.

Feline immunodeficiency virus infection: a valuable model to study HIV-1 associated encephalitis.

Prevalence and risk factors for hemoplasmas in domestic cats naturally infected with feline immunodeficiency virus and/or feline leukemia virus in Rio de Janeiro – Brazil

Oxidative stress during acute FIV infection in cats.

Vaccination against the feline immunodeficiency virus: the road not taken.

Feline immunodeficiency virus dendritic cell infection and transfer.

Evaluation of feline monocyte-derived dendritic cells loaded with internally inactivated virus as a vaccine against feline immunodeficiency virus.

[FELV infection, the kiss of death].

Transforming growth factor-beta/transforming growth factor-betaRII signaling may regulate CD4+CD25+ T-regulatory cell homeostasis and suppressor function in feline AIDS lentivirus infection.

Loss of naïve (CD45RA+) CD4+ lymphocytes during pediatric infection with feline immunodeficiency virus.

Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats.

Immunotherapy with internally inactivated virus loaded dendritic cells boosts cellular immunity but does not affect feline immunodeficiency virus infection course.